In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
Close this windowThis post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
If your practice would like to amend the types of vaccines your clinic will be administering or would like to withdraw from the COVID-19 vaccination program, contact CESPHN. You must notify your intention to withdraw or amend the types of vaccines your clinic will be administering in writing via email to coronavirus@cesphn.com.au. CSEPHN will pass this information onto the Taskforce to enable the accurate administration of the request.
Many children are now eligible for their second dose of their primary course of COVID-19 vaccine. Practices are encouraged to proactively reach out to parents and carers of children who have received their first dose of the vaccine and are now due for their second dose. Consider making appointments available through the school holidays, outside school hours and on the weekend.
Download the AIR042A report help identify children who are due for their second dose of COVID-19 vaccine. Need help downloading AIR42A report? Contact immunisation@cesphn.com.au for support.
ATAGI notes that the Therapeutic Goods Administration (TGA) has approved a booster dose of Comirnaty (Pfizer) COVID-19 vaccine for use in adolescents aged 12-15 years. However, at this time, ATAGI does not recommend that adolescents aged 12-15 years need to receive a booster dose of Pfizer COVID-19 vaccine.
ATAGI has updated document to include information about replacement dose advice for winter booster doses. See ATAGI clinical guidance on COVID-19 vaccine administration errors.
Annual vaccination is the most important measure to prevent influenza and its complications. The influenza vaccine is recommended for all individuals aged 6 months and over. This year Australians are more vulnerable to influenza due to lower recent exposure to the virus and lower uptake of influenza vaccines in 2021. With international borders reopening, it’s likely Australia will see more influenza in 2022.
See latest Influenza immunisation data – 1 March 2022 to 18 April 2022.
New analysis of human papillomavirus (HPV) vaccination coverage by researchers from NCIRS and the Australian Centre for the Prevention of Cervical Cancer has shown that although Australia is currently on track to eliminate targeted HPV types, an ongoing focus on equity in vaccine delivery systems to ensure course completion is needed.
Download the AIR10A report to identify adolescent patients overdue for their HPV vaccine from the Australian Immunisation Register. Need help downloading AIR10A report? Contact immunisation@cesphn.com.au for support.
Join the latest COVID-19 vaccine live stream update for GPs. The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout.
Details: Thursday 21 April 2022 at 3:30pm (AEDT) | Click link to join
Catch up on previous Immunisation Weekly Updates.
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. Randwick scientist and grandmother Hilda Stender shared this: What exercise did you do yesterday? I’ve had two knee replacements – one four years ago and the other six months ago. As a result,…
